Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Shibamoto T et al. PAF, rather than histamine, participates in mouse anaphylactic hypotension. 2008 Pharmacology pmid:18583921
Zhang XP et al. The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge. 2008 Dig. Dis. Sci. pmid:17597411
Smith JC et al. Identification of lysophosphatidylcholine (LPC) and platelet activating factor (PAF) from PC12 cells and mouse cortex using liquid chromatography/multi-stage mass spectrometry (LC/MS3). 2008 Rapid Commun. Mass Spectrom. pmid:18937225
Kihara Y et al. Platelet-activating factor production in the spinal cord of experimental allergic encephalomyelitis mice via the group IVA cytosolic phospholipase A2-lyso-PAFAT axis. 2008 J. Immunol. pmid:18802104
Wislet-Gendebien S et al. Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors. 2008 BMC Neurosci pmid:18808659
Zheng M et al. (3S)-N-(L-Aminoacyl)-1,2,3,4-tetrahydroisoquinolines, a class of novel antithrombotic agents: synthesis, bioassay, 3D QSAR, and ADME analysis. 2008 Bioorg. Med. Chem. pmid:18835178
Vadas P et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. 2008 N. Engl. J. Med. pmid:18172172
Burks AW Factoring PAF in anaphylaxis. 2008 N. Engl. J. Med. pmid:18172180
Menzies-Gow NJ et al. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses. 2008 Am. J. Vet. Res. pmid:18241016
Li J et al. PMS777, a bis-interacting ligand for PAF receptor antagonism and AChE inhibition, attenuates PAF-induced neurocytotoxicity in SH-SY5Y cells. 2008 Cell. Mol. Neurobiol. pmid:17712622
Hemetsberger R et al. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries. 2008 Coron. Artery Dis. pmid:19005299
Kasperska-Zajac A et al. Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. 2008 Recent Pat Inflamm Allergy Drug Discov pmid:19075994
XUE M et al. Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome. 2008 Chin J Integr Med pmid:19082798
Shiva D et al. High dose of lipopolysaccharide pre-treatment prevents OVA-induced anaphylactic decreases in rectal temperature in the immunized mice. 2008 Immunol. Lett. pmid:18433880
Leary PJ et al. A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18441203
Cooper D et al. Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow. 2008 J. Leukoc. Biol. pmid:18372340
Bansal AS et al. Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. 2008 N. Engl. J. Med. pmid:18389523
Okamoto H and Kamatani N Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. 2008 N. Engl. J. Med. pmid:18389524
Torres MI and Rios A Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. 2008 World J. Gastroenterol. pmid:18395894
Kim HA et al. Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis. 2008 Immunology pmid:18397269
Galli SJ and Franco CB Basophils are back! 2008 Immunity pmid:18400194
Levy JH Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. 2008 N. Engl. J. Med. pmid:18385504
Sreevidya CS et al. Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists. 2008 Cancer Res. pmid:18483284
Burks AW Peanut allergy. 2008 Lancet pmid:18456104
Huang GD et al. Effect of volatile oil of amomum on expressions of platelet activating factor and mastocarcinoma-related peptide in the gastric membrane of chronic gastritis patients with helicobacter-pylori infection. 2008 Chin J Integr Med pmid:18568325
Landgraf RG et al. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. 2007 Oct-Nov Prostaglandins Leukot. Essent. Fatty Acids pmid:17923399
Vadnais ML et al. Current concepts of molecular events during bovine and porcine spermatozoa capacitation. 2007 May-Jun Arch. Androl. pmid:17612869
Rosenwasser L New insights into the pathophysiology of allergic rhinitis. 2007 Jan-Feb Allergy Asthma Proc pmid:17390750
Hattermann K et al. The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis. 2007 FASEB J. pmid:17264163
De Vriese C et al. Ghrelin interacts with human plasma lipoproteins. 2007 Endocrinology pmid:17289852
Li SQ et al. Improving effect of Ginkgolide B on mitochondrial respiration of ischemic neuron after cerebral thrombosis in tree shrewa. 2007 Chin. Med. J. pmid:17908463
Doublier S et al. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase. 2007 Clin. Cancer Res. pmid:17908960
Shimada T et al. Cross-regulation of cortisol secretion by adrenocorticotropin and platelet-activating factor in perfused guinea pig adrenals. 2007 J. Endocrinol. pmid:17911394
Whitehead SN et al. Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry. 2007 Anal. Chem. pmid:17949058
Bixby CE et al. Role of platelet-activating factor in pulmonary vascular remodeling associated with chronic high altitude hypoxia in ovine fetal lambs. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17951313
Liu WC et al. Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist. 2007 Neurosci Bull pmid:17952135
Wu B et al. [Effects of bificobacterium longum on neonatal rat model of necrotizing enterocolitis and roles of platelet-activating factor and tumor necrosis factor-alpha]. 2007 Zhonghua Er Ke Za Zhi pmid:17953818
Owen JS et al. Platelet-activating factor. 2007 Meth. Enzymol. pmid:17954244
Ying-fang S et al. Effect of platelet-activating factor on cell proliferation & NF-kappaB activation in airway smooth muscle cells in rats. 2007 Indian J. Med. Res. pmid:17932440
Guerra CT et al. Effect of chronic hepatitis C virus infection on inflammatory lipid mediators. 2007 Dig Liver Dis pmid:17936229
Kawano Y et al. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a). 2007 Am. J. Reprod. Immunol. pmid:17922696
Keam SJ and Plosker GL Rupatadine: a review of its use in the management of allergic disorders. 2007 Drugs pmid:17335300
Van Overloop H et al. On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase. 2007 Biol. Chem. pmid:17338639
Ebihara S et al. A simple preparation method for mouse eosinophils and their responses to anti-allergic drugs. 2007 Inflamm. Res. pmid:17406808
Simonenko VB et al. [Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome]. 2007 Klin Med (Mosk) pmid:17564032
Li Y et al. Autocrine activation of ion currents in the two-cell mouse embryo. 2007 Exp. Cell Res. pmid:17583695
Martin J et al. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. 2007 Curr. Pharm. Des. pmid:17584105
Ferreira MA et al. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). 2007 Life Sci. pmid:17588613
Xia SH et al. Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021. 2007 World J. Gastroenterol. pmid:17589953
Tosaki T et al. Enhancement of acetyl-CoA: 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity by hydrogen peroxide. 2007 Biol. Pharm. Bull. pmid:17268064
Zhang X et al. Down-regulation of platelet-activating factor receptor gene expression during focal reversible cerebral ischemia in rats. 2007 Neurochem. Res. pmid:17268849
Sandford RM et al. The genetic basis of abdominal aortic aneurysms: a review. 2007 Eur J Vasc Endovasc Surg pmid:17276705
Slomiany BL and Slomiany A Interference by leptin with Helicobacter pylori lipopolysaccharide-induced cytosolic phospholipase A2 activation in gastric mucosal cells. 2007 J. Physiol. Pharmacol. pmid:17440231
Ullrich SE Sunlight and skin cancer: lessons from the immune system. 2007 Mol. Carcinog. pmid:17443748
Richter M et al. Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17448648
Finnegan EM et al. Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17483236
Cattaneo M et al. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. 2007 Haematologica pmid:17488697
Kälvegren H et al. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. 2007 Eur. J. Pharmacol. pmid:17459368
Taheri F and Bazan HE Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells. 2007 Invest. Ophthalmol. Vis. Sci. pmid:17460244
Dinubile MJ Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin". 2007 Am. J. Physiol., Cell Physiol. pmid:17428843
Souza LJ et al. Acute pancreatitis affects non-parenchymal liver cells by a mechanism dependent on platelet-activating factor. 2007 Pancreatology pmid:17449968
Shin CR et al. Differential platelet-activating factor synthesis by monocytes and polymorphonuclear leukocytes from subjects with localized aggressive periodontitis. 2007 J. Periodont. Res. pmid:17451539
Truffinet V et al. No effect of platelet-activating factor on the proliferation and apoptosis of immature forms of leukemic blasts. 2007 Leuk. Res. pmid:17350684
Zhao W et al. [Effect of PAF on the expression of PACAP mRNA in the granulosa cells of rat ovary]. 2007 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21180114
Paterson WG et al. Role of platelet-activating factor in acid-induced esophageal mucosal injury. 2007 Dig. Dis. Sci. pmid:17415649
Tsimikas S et al. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17626905
Viergutz T and Löhrke B Role of the platelet-activating factor and its receptor in the proliferative regulation of bovine ovarian granulosa cells. 2007 Cell Prolif. pmid:18021181
Chen Q et al. The yeast acylglycerol acyltransferase LCA1 is a key component of Lands cycle for phosphatidylcholine turnover. 2007 FEBS Lett. pmid:17996202
Ezoulin MJ et al. A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine. 2007 Int. Immunopharmacol. pmid:17996678
Xavier RG et al. Enhanced platelet aggregation and activation under conditions of hypothermia. 2007 Thromb. Haemost. pmid:18064324
Dunkel B et al. Platelet activation in ponies with airway inflammation. 2007 Equine Vet. J. pmid:18065316
Lu SM et al. The phospholipid mediator platelet-activating factor mediates striatal synaptic facilitation. 2007 J Neuroimmune Pharmacol pmid:18040844
Rockel N et al. The osmolyte taurine protects against ultraviolet B radiation-induced immunosuppression. 2007 J. Immunol. pmid:17785795
Tsantila N et al. Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbits. 2007 Mediators Inflamm. pmid:18253466
Li J et al. Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity. 2007 Int. J. Neuropsychopharmacol. pmid:16426477
Melnikova V and Bar-Eli M Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. 2007 Cancer Metastasis Rev. pmid:17721743
Lo GK et al. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? 2007 Am. J. Hematol. pmid:17722079
Chen J et al. Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis. 2007 J. Lipid Res. pmid:17693621
Takahashi T et al. Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells. 2007 Microvasc. Res. pmid:17027041
Shi W et al. [Study on composing mechanism by effect of disassembled compositions of Yiqi Huoxue decoction on platelet aggregation of health adults]. 2007 Zhongguo Zhong Yao Za Zhi pmid:18309677
Kuckleburg CJ et al. Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation. 2007 Infect. Immun. pmid:17118985
Ibe BO et al. Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle. 2007 J. Pharmacol. Exp. Ther. pmid:17085546
Saluk-Juszczak J et al. The effect of lipopolysaccharide from Proteus mirabilis on the level of the stable end metabolic products of nitric oxide in blood platelets. 2007 Curr. Microbiol. pmid:17160361
Huang YH et al. Suppression effect of seminal vesicle autoantigen on platelet-activating factor-induced mouse sperm capacitation. 2007 J. Cell. Biochem. pmid:17131380
Osborn TM et al. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. 2007 Am. J. Physiol., Cell Physiol. pmid:17135294
Bathgate R et al. Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters. 2007 Theriogenology pmid:17157372
Hammond A et al. Platelets in equine recurrent airway obstruction. 2007 Res. Vet. Sci. pmid:17107696
Vinores SA et al. TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage. 2007 J. Neuroimmunol. pmid:17107717
Brkovic A and Sirois MG Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis. 2007 J. Cell. Biochem. pmid:17115409
Choi JH et al. Impairment of p38 MAPK-mediated cytosolic phospholipase A2 activation in the kidneys is associated with pathogenicity of Candida albicans. 2007 Immunology pmid:17054728
El Behi M et al. Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs. 2007 J. Neuroimmunol. pmid:17097744
Blanchet MR et al. Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. 2007 J. Leukoc. Biol. pmid:17289799
Shindou H et al. A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase. 2007 J. Biol. Chem. pmid:17182612
Ko HM et al. Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis. 2007 Int. J. Cancer pmid:17187368
Bate C et al. Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage. 2007 J Neuroinflammation pmid:17233902
Caini P et al. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection. 2007 J. Viral Hepat. pmid:17212640
Park EJ et al. Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide. 2007 Shock pmid:17510604
Young RE et al. Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice. 2007 Br. J. Pharmacol. pmid:17471175
Steel HC et al. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4. 2007 Clin. Exp. Immunol. pmid:17683509
Eckert RE and Jones SL Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant. 2007 J. Leukoc. Biol. pmid:17684042